Sukhyang Lee Selected Research

DA 8031

7/2014	Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
3/2014	Effect of DA-8031, a novel oral compound for premature ejaculation, on male rat sexual behavior.
4/2013	Ejaculatory responses are inhibited by a new chemical entity, DA-8031, in preclinical rodent models of ejaculation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sukhyang Lee Research Topics

Disease

4	Hemorrhage 01/2020 - 11/2003
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2020 - 01/2016
3	Premature Ejaculation 07/2014 - 04/2013
2	Dementia (Dementias) 02/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2016
2	Hypertension (High Blood Pressure) 01/2020 - 11/2016
2	Type 2 Diabetes Mellitus (MODY) 04/2019 - 01/2018
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 11/2018
2	Diabetes Mellitus 11/2016 - 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Diabetes Complications 04/2019
1	Cerebral Hemorrhage 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Stroke (Strokes) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Myocardial Infarction 02/2018
1	Disease Progression 02/2018
1	Ischemic Stroke 02/2018
1	Cardiac Arrhythmias (Arrythmia) 09/2015
1	Flushing 01/2014
1	Hyperphosphatemia 01/2014
1	Liver Diseases (Liver Disease) 07/2009

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2020 - 01/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 11/2016
3	Angiotensin Receptor AntagonistsIBA 11/2018 - 11/2016
3	DA 8031IBA 07/2014 - 04/2013
2	sarpogrelateIBA 04/2019 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2019 - 01/2018
2	Cilostazol (Pletal)FDA LinkGeneric 02/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 09/2015 - 01/2014
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 07/2014 - 03/2014
2	Warfarin (Coumadin)FDA LinkGeneric 03/2007 - 11/2003
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2019
1	Metformin (Glucophage)FDA LinkGeneric 04/2019
1	AldosteroneIBA 04/2019
1	AngiotensinsIBA 04/2019
1	ReninIBA 04/2019
1	LipidsIBA 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	ThiazidesIBA 11/2016
1	Monoclonal AntibodiesIBA 09/2015
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 07/2014
1	benzylamineIBA 07/2014
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2014
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2014
1	MK-0524IBA 01/2014
1	SuspensionsIBA 01/2014
1	p-ChloroamphetamineIBA 04/2013
1	Losartan (Cozaar)FDA LinkGeneric 07/2009
1	HM70186IBA 07/2009
1	Antihypertensive Agents (Antihypertensives)IBA 07/2009
1	Cytochrome P-450 CYP2C19IBA 03/2007
1	Cytochrome P-450 CYP2C9IBA 11/2003

Therapy/Procedure

6	Therapeutics 04/2019 - 11/2003
1	Secondary Prevention 01/2019
1	Transplantation 02/2018
1	Renal Dialysis (Hemodialysis) 02/2018